Skip to content

13F-HR filed by Camber Capital Management LP

Camber Capital Management LP filed this 13F-HR for the quarter ended 2020-06-30, filed 2020-08-14, with 30 holding rows worth $1,747,847,000.

Accession
0001654954-20-009100
Filed
2020-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2020

A holdings report, 30 entries on the cover page, a total value of $1,747,847,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,747,847,000 with VALUE read as thousands by filing date, 13F file number 028-13745. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CHANGE HEALTHCARE INC15912K100COM15,900,000$178,080,000thousands by filing date
MYLAN NVN59465109SHS EURO11,000,000$176,880,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM1,400,000$157,136,000thousands by filing date
ALKERMES PLCG01767105SHS7,250,000$140,686,000thousands by filing date
PERRIGO CO PLC SHSG97822103Stock2,250,000$124,358,000thousands by filing date
GLAXOSMITHKLINE PLC-ADR37733W105SPONSORED ADR3,000,000$122,370,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock1,000,000$92,890,000thousands by filing date
BLUEBIRD BIO INC09609G100COM1,275,000$77,826,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM3,000,000$69,480,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK6,500,000$67,080,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM400,000$64,136,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR350,000$51,765,000thousands by filing date
MYRIAD GENETICS INC62855J104COM4,000,000$45,360,000thousands by filing date
BROOKDALE SR LIVING INC112463104COM15,000,000$44,250,000thousands by filing date
COHERUS ONCOLOGY INC19249H103COM2,200,000$39,292,000thousands by filing date
COLLEGIUM PHARMACEUTICAL INC19459J104COM2,000,000$35,000,000thousands by filing date
AMAG PHARMACEUTICALS INC00163U106COM4,390,000$33,584,000thousands by filing date
GLAUKOS CORP COM377322102Stock730,000$28,047,000thousands by filing date
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK2,400,000$25,032,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR2,000,000$24,660,000thousands by filing date
TECTONIC THERAPEUTIC INC COM05455M100Stock1,350,000$23,558,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM525,000$21,830,000thousands by filing date
ATARA BIOTHERAPEUTICS INC COM NEW046513107Stock1,400,000$20,398,000thousands by filing date
IMMUNOVANT INC45258J102COM800,000$19,480,000thousands by filing date
TRANSLATE BIO INC.89374L104Common Stock1,000,000$17,920,000thousands by filing date
MOMENTA PHARMACEUTICALS INC60877T100COM450,000$14,972,000thousands by filing date
GLYCOMIMETICS INC38000Q102COM3,000,000$11,280,000thousands by filing date
PACIFIC BIOSCIENCES CALIF IN06404D908COM3,110,000$10,730,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW375,000$5,111,000thousands by filing date
SUTRO BIOPHARMA INC869367102COM600,000$4,656,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001654954-20-009100this filing2020-08-14acceptance time not in the bulk data set